Studies show that people taking the 7.2 mg dose of Wegovy lost an average of about 18.7% of their body weight, compared with about 15.6% for people taking the 2.4 mg dose
Amphetamine is currently marketed under other brand names (e.g
A recent meta-analysis encompassing 11 observational and case-control studies across various countries revealed no statistically significant disparity in suicidal outcomes between GLP-1 RA users and those utilizing alternative antihyperglycemic medications (relative risk, 0.57
Whats more, its demographic analysis showed significant differences between the GLP-1 RA and comparator groups in factors such as age, HbA1c, body weight, BMI, duration of diabetes, sex, race, and so on, suggesting that the effect of GLP-1RAs on DR is yet controversial and that it may vary based on the specific GLP-1RA used, as well as the patients demographic and clinical characteristics